Literature DB >> 6242052

The clinical pharmacology of appetite suppressant drugs.

T Silverstone, E Goodall.   

Abstract

One way of gaining a greater understanding of the central mechanisms underlying hunger and the regulation of feeding behaviour in humans is to examine the actions and interactions on hunger and food intake of drugs with known or presumed pharmacological modes of action. To this end we have undertaken a number of studies which fall into three main categories: the mechanisms by which amphetamine anorexia is induced; the possible role of endogenous opioids in feeding; the action of amino acids thought to be involved in the regulation of feeding. In this field the potential for cross-fertilization between basic scientists working with laboratory animals and clinical scientists working with human subjects exists. For example, the clinical pharmacologist has been able to test out hypotheses on human subjects which could only have been developed using laboratory animals. Furthermore, using human subjects it is possible to extend the field of inquiry into an exploration of the subjective dimensions of appetite and hunger.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6242052

Source DB:  PubMed          Journal:  Int J Obes


  4 in total

Review 1.  Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Authors:  Jason C G Halford; Joanne A Harrold; Emma J Boyland; Clare L Lawton; John E Blundell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  [The effect of tryptophan on the regulation of food intake in normal and overweight persons].

Authors:  A Frank; E Menden
Journal:  Z Ernahrungswiss       Date:  1994-09

3.  The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study.

Authors:  Elias E Mazokopakis; Maria G Papadomanolaki; Andreas A Fousteris; Dimitrios A Kotsiris; Ioannis M Lampadakis; Emmanuel S Ganotakis
Journal:  Ann Gastroenterol       Date:  2014

4.  The effect of Spirulina sauce, as a functional food, on cardiometabolic risk factors, oxidative stress biomarkers, glycemic profile, and liver enzymes in nonalcoholic fatty liver disease patients: A randomized double-blinded clinical trial.

Authors:  Seyed Mohammad Mazloomi; Mohammad Samadi; Hajar Davarpanah; Siavash Babajafari; Cain C T Clark; Zohreh Ghaemfar; Mojtaba Rezaiyan; Abdolhamid Mosallanezhad; Maryam Shafiee; Hosein Rostami
Journal:  Food Sci Nutr       Date:  2021-06-11       Impact factor: 2.863

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.